Clinical Trial Update: Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating chemotherapy with Filgrastim and peripheral stem cell transplantation in patients with chronic myeloid leukemia. The study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia | Phase 2 | Status: TERMINATED